Use of gene recombination human lysozyme against drug resistant bacteria in preparation of medicine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 长春奇龙生物技术研究所
- Publication Date
- 2003-09-03
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
Technical field:
[0001] The invention relates to a new application of gene recombinant human lysozyme, in particular to the new application of gene recombinant human lysozyme in targeting drug-resistant bacteria in the field of pharmacy. Background technique:
[0002] Antibiotics have created many medical miracles and made many diseases disappear without a trace, such as pneumonia, meningitis, puerperal fever, sepsis, tuberculosis, etc. Today in the 21st century, the development of drug-resistant bacteria is shocking. For example, penicillin-resistant Streptococcus pneumoniae was very sensitive to penicillin, erythromycin, sulfonamide and other drugs in the past, but now it is almost "invulnerable". The resistance of Klebsiella pneumoniae to 16 kinds of high-end antibiotics such as Xilixin and Fudaxin is as high as 51.85%-100%. Methicillin-resistant Staphylococcus aureus (MRSA) has no cure except vancomycin. It can be seen from the development history of bacterial drug re...